Failures in Clinical Trials in the European Union: Lessons from the Polish Experience

Science and Engineering Ethics 19 (3):1087-1098 (2013)
  Copy   BIBTEX

Abstract

When discussing the safety of research subjects, including their exploitation and vulnerability as well as failures in clinical research, recent commentators have focused mostly on countries with low or middle-income economies. High-income countries are seen as relatively safe and well-regulated. This article presents irregularities in clinical trials in an EU member state, Poland, which were revealed by the Supreme Audit Office of Poland (the NIK). Despite adopting many European Union regulations, including European Commission directives concerning Good Clinical Practice, these irregularities occurred. Causes as well as potential solutions to make clinical trials more ethical and safer are discussed

Similar books and articles

The Protection of Patients' Rights in Clinical Trials.Marek Czarkowski - 2006 - Science and Engineering Ethics 12 (1):131-138.
Uncertainty and the Ethics of Clinical Trials.Sven Ove Hansson - 2006 - Theoretical Medicine and Bioethics 27 (2):149-167.
Informed Consent in Emergency Research: A Contradiction in Terms.Malcolm G. Booth - 2007 - Science and Engineering Ethics 13 (3):351-359.
The Research Misconception.Maurie Markman - 2004 - International Journal of Applied Philosophy 18 (2):241-252.
What Makes Placebo-Controlled Trials Unethical?Franklin G. Miller & Howard Brody - 2002 - American Journal of Bioethics 2 (2):3 – 9.
Prudent Precaution in Clinical Trials of Nanomedicines.Gary E. Marchant & Rachel A. Lindor - 2012 - Journal of Law, Medicine and Ethics 40 (4):831-840.

Analytics

Added to PP
2012-10-06

Downloads
244 (#48,739)

6 months
23 (#45,390)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Marcin Waligora
Jagiellonian University